U.S. markets open in 1 hour 20 minutes

OKYO Pharma Limited (OKYO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.10000.0000 (0.00%)
At close: 04:00PM EDT
2.1000 0.00 (0.00%)
After hours: 06:37PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close2.1000
Bid2.1000 x 1000
Ask2.3700 x 800
Day's Range2.1000 - 2.3800
52 Week Range1.8800 - 6.1100
Avg. Volume155,334
Market Cap49.007M
Beta (5Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.0070
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for OKYO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OKYO Pharma Limited
    The Argus Dividend Growth Model PortfolioDividend income, an important element of total return, is often overlooked amid gyrations in the stock market. Between 1930 and 2012, dividend income accounted for 42% of the total return of the S&P 500, according to Hartford Funds. And that's just the average. In some decades, dividends accounted for more than 50% of total returns and even 100% of returns. More recently, dividends have accounted for 15%-20% of returns. Still, in 2018, dividend payments softened the blow when most market indices declined as the Federal Reserve hiked rates. The pattern is being repeated in 2022 as well. Not all dividends are created equal, though, and it is important to understand the difference between the two main categories: high-yield stocks and dividend-growth stocks.
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    OKYO Pharma Limited - PDMR Dealing

    LONDON and NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a bio-pharmaceutical company focused on developing an innovative approach to dry eye care and ocular pain, today announces that it has been notified that Willy Simon, a non-executive director, purchased an aggregate of 361,195 ordinary shares of no par value ("Ordinary Shares") at a prices between £0.02679 and £0.0284 each. 1.Details of PDMR / person closely associateda)NameWilly Simon2.Reason f

  • GlobeNewswire

    OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing

    LONDON, May 19, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, today announced the closing of its underwritten public offering of 625,000 American Depository Shares (the “ADSs”) at a public offering price of $4.00 per share, for gross proceeds of $2.5 million, before deducting underwriting discounts a

  • Simply Wall St.

    Here's Why We're Watching OKYO Pharma's (LON:OKYO) Cash Burn Situation

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...